Michael Meyers is a director on the board of AEterna Zentaris. He is the CEO of Arcoda copital Management. He manage global health care fund. He is serving as an administrator of AEterna Zentaris. So is he considered as an insider of AEterna Zentaris? Anyone know?
Meyers, Michael Brief BiographyMr. Michael E. Meyers, MPH, is Independent Director of Aeterna Zentaris Inc. is a co-founding member, Chief Executive Officer and Chief Investment Officer of Arcoda Capital Management LP ("Arcoda"), a private investment fund manager. Prior to founding Arcoda in 2007, Mr. Meyers was a Partner and Portfolio Manager of two other money management firms located in New York. Between 2000 and 2003 Mr. Meyers was a Managing Director, Partner and Director of a life sciences venture capital firm located in New York and Zurich, Switzerland. Between 1997 and 2000, Mr. Meyers was Director, Biotechnology and Pharmaceutical Investment Banking at Merrill Lynch & Co. Between 1993 and 1997, Mr. Meyers was Vice President, Health Care Investment Banking at Cowen & Company. Prior to Cowen & Company, Mr. Meyers was Special Assistant to the Chief Executive Officer of St. Barnabas Hospital System. Mr. Meyers began his career as a Biotechnology and Medical Device Research Associate at Hambrecht & Quist in New York. Mr. Meyers holds an M.P.H. in Health Policy and Management from Columbia University and an A.B. in Biology from Brandeis University in Massachusetts. Mr. Meyers has also served on the Board of Directors of six companies times.
If he's on the board, he's an insider. His fund probably just got bored with aezs and moved to other bio's they think will move sooner. See if arcodia put money in bpax yesterday, lol. FDA decision coming on bpax within days or hours.